HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?

Abstract : Background France is the European country with the lowest level of confidence in vaccines. Measurement of patients’ acceptability towards a future therapeutic HIV vaccine is critically important. Thus, the aim of this study was to evaluate patients’ acceptability of a future therapeutic HIV vaccine in a representative cohort of French patients living with HIV-AIDS (PLWHs). Methods This multicentre study used quantitative and qualitative methods to assess PLWHs’ opinions and their potential acceptance of a future therapeutic HIV vaccine. Cross-sectional study on 220 HIV-1 infected outpatients, aged 18–75 years. Results The participants’ characteristics were similar to those of the overall French PLWH population. Responses from the questionnaires showed high indices of acceptance: the mean score for acceptability on the Visual Analog Scale VAS was 8.4 of 10, and 92% of patients agreed to be vaccinated if a therapeutic vaccine became available. Acceptability depended on the expected characteristics of the vaccine, notably the duration of its effectiveness: 44% of participants expected it to be effective for life. This acceptance was not associated with socio-demographic, clinical (mode of contamination, duration of disease), quality of life, or illness-perception parameters. Acceptability was also strongly correlated with confidence in the treating physician. Conclusion The PLWHs within our cohort had high indices of acceptance to a future therapeutic HIV vaccine.
Complete list of metadata

Cited literature [39 references]  Display  Hide  Download

Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Friday, May 22, 2020 - 9:38:33 AM
Last modification on : Friday, December 10, 2021 - 5:08:08 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License




Svetlane Dimi, David Zucman, Olivier Chassany, Christophe Lalanne, Thierry Prazuck, et al.. Patients’ high acceptability of a future therapeutic HIV vaccine in France: a French paradox?. BMC Infectious Diseases, BioMed Central, 2019, 19 (1), ⟨10.1186/s12879-019-4056-6⟩. ⟨hal-02263740⟩



Record views


Files downloads